Edward S. Kim

18.6k citations

216 papers · 9.8k indexed · 2 hit papers · h-index 52

Impact in

Oncology top 0.2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in

Pulmonary and Respiratory Medicine 138
- Lung Cancer Treatments and Mutations 116
- Lung Cancer Diagnosis and Treatment 34
Oncology 114
- Lung Cancer Research Studies 35
- Colorectal Cancer Treatments and Studies 28
- HER2/EGFR in Cancer Research 16
- Cancer Immunotherapy and Biomarkers 16

Co-authors: Waun Ki Hong J. Jack Lee Roy S. Herbst Scott M. Lippman Fadlo R. Khuri Ho‐Young Lee William N. William Kathryn A. Gold
Journals: Journal of Clinical Oncology (61 papers)Journal of Thoracic Oncology (16 papers)Clinical Cancer Research (12 papers)American Society of Clinical Oncology Educational Book (10 papers)Cancer Research (8 papers)
Partner nations: United States Spain Germany

In The Last Decade

Edward S. Kim

210 papers receiving 9.7k citations

Hit Papers

align trajectories log scale

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial 2017 · 430 citations

Peers

Countries citing papers authored by Edward S. Kim

Since Specialization

Citations

This map shows the geographic impact of Edward S. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward S. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward S. Kim more than expected).

Fields of papers citing papers by Edward S. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward S. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward S. Kim. The network helps show where Edward S. Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward S. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward S. Kim Line = papers co-authored together Edward S. Kim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials Journal of Clinical Oncology ·Paul Frankel, Susan Groshen, Jan H. Beumer, Laura Cleveland, Edward S. Kim, Judith E. Karp	2023	3
2	Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO- Friends Recommendations Clinical Cancer Research ·R. Donald Harvey, Suanna S. Bruinooge, Li Chen, Elizabeth Garrett‐Mayer, Whitney Rhodes, Edward Stepanski, Thomas S. Uldrick, Gwynn Ison, Sean Khozin, Wendy S. Rubinstein, Caroline Schenkel, Robert S. Miller, George A. Komatsoulis, Richard L. Schilsky, Edward S. Kim	2021	29
3	Egfr Tyrosine Kinase Inhibitors for EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Outcomes in Asian Populations Future Oncology ·Edward S. Kim, Barbara Melosky, Keunchil Park, Nobuyuki Yamamoto, James Chih‐Hsin Yang	2021	18
4	Detection of NRG1 Gene Fusions in Solid Tumors Clinical Cancer Research ·Sushma Jonna, Rebecca Feldman, Jeffrey Swensen, Zoran Gatalica, W. Michael Korn, Hossein Borghaei, C. Patrick, Jorge J. Nieva, Alexander I. Spira, Ari M. Vanderwalde, Antoinette J. Wozniak, Edward S. Kim, Stephen V. Liu	2019	155
5	Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study Clinical Cancer Research ·Edward S. Kim, Karen Kelly, Luis Paz‐Ares, Pilar Garrido, Shadia I. Jalal, Daruka Mahadevan, Martin Gutierrez, Mariano Provencio, Eric Schaefer, Monte Shaheen, Erica L. Johnston, P. Kellie Turner, Siva Rama Prasad Kambhampati, Richard P. Beckmann, Anwar Hossain, William J. John, Jonathan W. Goldman	2018	17
6	Precision Oncology: Who, How, What, When, and When Not? American Society of Clinical Oncology Educational Book ·Lee S. Schwartzberg, Edward S. Kim, David Liu, Deborah Schrag	2017	166
7	Transforming Clinical Trial Eligibility Criteria to Reflect Practical Clinical Application American Society of Clinical Oncology Educational Book ·Edward S. Kim, Jennifer Atlas, Gwynn Ison, Jennifer L. Ersek	2016	16
8	Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors Clinical Cancer Research ·Robin L. Jones, Edward S. Kim, Pilar Nava-Parada, Salma Alam, Faye M. Johnson, Andrew Stephens, Ronit Simantov, Srinivasu Poondru, Rich Gedrich, Scott M. Lippman, Stan B. Kaye, Craig P. Carden	2014	77
9	Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma Clinical Cancer Research ·Ignacio I. Wistuba, Carmen Behrens, Francesca Lombardi, Susanne Wagner, Junya Fujimoto, Maria Gabriela Raso, Lorenzo Spaggiari, Domenico Galetta, Robyn Riley, Elisha Hughes, Julia Reid, Zaina Sangale, S.G. Swisher, Neda Kalhor, César A. Moran, Alexander Gutin, Jerry S. Lanchbury, Massimo Barberis, Edward S. Kim	2013	84
10	Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·James W. Welsh, Ritsuko Komaki, Arya Amini, Mark F. Munsell, Wyatt Unger, Pamela K. Allen, Joe Y. Chang, Jeffrey S. Wefel, Susan L. McGovern, Linda L. Garland, Su S. Chen, J.A. Holt, Zhongxing Liao, Paul D. Brown, Erik P. Sulman, John V. Heymach, Edward S. Kim, Baldassarre Stea	2013	314
11	Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy Clinical Cancer Research ·Kathryn A. Gold, Edward S. Kim, Diane D. Liu, Ping Yuan, Carmen Behrens, Luisa M. Solis, Humam Kadara, David C. Rice, Ignacio I. Wistuba, Stephen G. Swisher, Wayne L. Hofstetter, J. Jack Lee, Waun Ki Hong	2013	27
12	Identification of a Subset of Human Non–Small Cell Lung Cancer Patients with High PI3Kβ and Low PTEN Expression, More Prevalent in Squamous Cell Carcinoma Clinical Cancer Research ·Marie Cumberbatch, Ximing Tang, Garry Beran, Sonia Eckersley, Xin Wang, Rebecca Ellston, Simon Dearden, Sabina Cosulich, Paul D. Smith, Carmen Behrens, Edward S. Kim, Xinying Su, Shuqiong Fan, Neil Gray, David P. Blowers, Ignacio I. Wistuba, Chris Womack	2013	22
13	Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling Cancer Prevention Research ·Humam Kadara, Li Shen, Junya Fujimoto, Pierre Saintigny, Chi‐Wan Chow, Wenhua Lang, Zuoming Chu, Melinda Garcia, Mohamed Kabbout, You-Hong Fan, Carmen Behrens, Diane A. Liu, Li Mao, J. Jack Lee, Kathryn A. Gold, Jing Wang, Kevin R. Coombes, Edward S. Kim, Waun Ki Hong, Ignacio I. Wistuba	2012	26
14	Gene Expression Profiling Predicts the Development of Oral Cancer Cancer Prevention Research ·Pierre Saintigny, Li Zhang, You-Hong Fan, Adel K. El‐Naggar, Vassiliki A. Papadimitrakopoulou, Lei Feng, J. Jack Lee, Edward S. Kim, Waun Ki Hong, Li Mao	2011	109
15	Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers Cancer Prevention Research ·Edward S. Kim, Waun Ki Hong, J. Jack Lee, Li Mao, Rodolfo C. Morice, Diane D. Liu, Carlos A. Jiménez, Georgie A. Eapen, Reuben Lotan, Ximing Tang, Robert A. Newman, Ignacio I. Wistuba, Jonathan M. Kurie	2010	39
16	Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer Cancer Prevention Research ·Mohammed Taoudi Benchekroun, Pierre Saintigny, Sufi M. Thomas, Adel K. El‐Naggar, Vassiliki A. Papadimitrakopoulou, Hening Ren, Wenhua Lang, You-Hong Fan, Jianhua Huang, Lei Feng, J. Jack Lee, Edward S. Kim, Waun Ki Hong, Faye M. Johnson, Jennifer R. Grandis, Li Mao	2010	88
17	High-Dose Fenretinide in Oral Leukoplakia Cancer Prevention Research ·William N. William, J. Jack Lee, Scott M. Lippman, Jack W. Martin, Nitin Chakravarti, Hai T. Tran, Anita L. Sabichi, Edward S. Kim, Lei Feng, Reuben Lotan, Vassiliki A. Papadimitrakopoulou	2009	33
18	Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development Cancer Research ·Woo-Young Kim, Quanri Jin, Seung-Hyun Oh, Edward S. Kim, Youn Joo Yang, Dong Hoon Lee, Lei Feng, Carmen Behrens, Ludmila Prudkin, York E. Miller, J. Jack Lee, Scott M. Lippman, Waun Ki Hong, Ignacio I. Wistuba, Ho‐Young Lee	2009	60
19	Oral Epithelium as a Surrogate Tissue for Assessing Smoking-Induced Molecular Alterations in the Lungs Cancer Prevention Research ·Manisha Bhutani, Ashutosh Pathak, You-Hong Fan, Diane D. Liu, J. Jack Lee, Hongli Tang, Jonathan M. Kurie, Rodolfo C. Morice, Edward S. Kim, Waun Ki Hong, Li Mao	2008	70
20	Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib Cancer Research ·Floriana Morgillo, Jong Kyu Woo, Edward S. Kim, Waun Ki Hong, Ho‐Young Lee	2006	275

About Edward S. Kim

Edward S. Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology, Cancer Research and Periodontics, having authored 216 papers that have together received 9.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (116 papers), Cancer Genomics and Diagnostics (47 papers), Lung Cancer Research Studies (35 papers), Lung Cancer Diagnosis and Treatment (34 papers), Colorectal Cancer Treatments and Studies (28 papers), Head and Neck Cancer Studies (17 papers), HER2/EGFR in Cancer Research (16 papers) and Cancer Immunotherapy and Biomarkers (16 papers). The work is most often cited by research in Oncology (5.2k citations), Pulmonary and Respiratory Medicine (5.3k citations), Cancer Research (1.9k citations), Otorhinolaryngology (459 citations) and Periodontics (204 citations). Edward S. Kim has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Waun Ki Hong, J. Jack Lee, Roy S. Herbst, Scott M. Lippman, Fadlo R. Khuri, Ho‐Young Lee, William N. William, Kathryn A. Gold, Floriana Morgillo and Mark A. Socinski. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Cancer Research, American Society of Clinical Oncology Educational Book and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact